Dr Jonathan Treem joins Ethics Talk to discuss his article, coauthored with Drs Joel Yager and Jennifer L. Gaudiani: “A Life-Affirming Palliative Care Model for Severe and Enduring Anorexia Nervosa.”
The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.
Physicians have a responsibility to balance patient confidentiality and full disclosure to the family of adolescent patients with eating disorders in order to provide optimal treatment.
When a dual relationship exists between a physician and a patient, the physician has an obligation to put the patient's health first even at the risk of ending the personal relationship.
Physicians need to perform their due diligence and practice caution when prescribing addictive pain medications to relieve their patients' chronic pain due to increased federal monitoring of pain prescriptions.